The $4 Million Mistake Most HealthTech Founders Make Delaying Refactoring Before Exit

I've watched teams build incredible products only to stumble at the finish line. In my experience, unaddressed technical debt in HealthTech isn't just an engineering headache. It's a direct threat to your acquisition valuation. Every time a buyer's technical team runs due diligence, they aren't just looking at features. They're digging into performance bottlenecks like Core Web Vitals, checking for SEO continuity gaps, and looking closely at brittle domain boundaries. What I've found is these issues depress buyer interest and valuation multiples. You're only as good as your domain boundaries, and messy code tells a story you don't want buyers to read.

Last year I dealt with a client who thought their .NET platform was 'good enough' for another six months. What I've found is this mindset costs them dearly. Every month you keep a legacy .NET monolith, you lose two sprints of velocity. That's roughly $30k of engineering time burned. Beyond that, spaghetti code depresses acquisition valuation by 20-40% when buyers run technical due diligence. On a $20M paper valuation, that's $4M-$8M left on the table. This isn't about improvement. It's about stopping the bleeding.

I always tell teams that founders often believe refactoring is a cost center, not a value driver. They prioritize new features, thinking 'we'll fix it later.' Here's what I learned the hard way. That belief is wrong. The real problem is they underestimate the cost of inaction. I've seen this happen when teams think a quick feature hack will push them over the line for a Series B. But those hacks create the spaghetti code buyers dread. This isn't just about making things cleaner. It's about removing a burden that screams 'risk' during technical due diligence.

What actually works in production is a smart approach to modernization. I’ve seen this change companies. My approach to a top-to-bottom modernization often means moving a legacy .NET frontend to Next.js 15. This isn't just a tech upgrade. It's about building acquisition-ready code. We focus on clean architecture, solid domain boundaries, and performance tuning for Core Web Vitals. This buys back your exit timeline. It shows buyers a forward-thinking, maintainable system that’s built for growth and long-term value, not just short-term feature pushes.

If your dev team keeps saying 'it's almost done' for weeks, your Core Web Vitals are failing, and due diligence keeps pointing out 'technical debt', your legacy platform isn't helping. It's hurting. This is literally your situation. Every week you ship late, you're burning runway you can't get back. The competitors who ship faster are capturing the customers you're losing. This isn't about being better next quarter. It's about surviving this one and securing your exit.

I fixed this exact situation for a SaaS company where their outdated frontend meant features took six weeks to ship. After migrating their core components to Next.js and putting in place proper domain boundaries, they were shipping in four days within three weeks. This isn't about improvement. It's about stopping active damage. If your HealthTech SaaS is approaching a Series B or acquisition, and you fear hidden technical debt could derail your valuation, don't wait for due diligence to expose it.